Raymond James & Associates Vericel Corp Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Vericel Corp stock. As of the latest transaction made, Raymond James & Associates holds 50,908 shares of VCEL stock, worth $2.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,908
Previous 47,825 6.45%
Holding current value
$2.91 Million
Previous $2.19 Million 2.01%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$42.25 - $53.56 $130,256 - $165,125
3,083 Added 6.45%
50,908 $2.15 Million
Q2 2024

Jul 19, 2024
SELL
$41.71 - $52.9 $25,359 - $32,163
-608 Reduced 1.26%
47,825 $2.19 Million
Q1 2024

Apr 22, 2024
SELL
$32.52 - $52.33 $2,861 - $4,605
-88 Reduced 0.18%
48,433 $2.52 Million
Q4 2023

Jan 16, 2024
SELL
$30.85 - $37.09 $3,979 - $4,784
-129 Reduced 0.27%
48,521 $1.73 Million
Q3 2023

Oct 24, 2023
BUY
$31.69 - $39.25 $143,016 - $177,135
4,513 Added 10.22%
48,650 $1.63 Million
Q2 2023

Jul 25, 2023
BUY
$29.0 - $38.37 $39,904 - $52,797
1,376 Added 3.22%
44,137 $1.66 Million
Q1 2023

Apr 14, 2023
BUY
$23.85 - $31.34 $55,379 - $72,771
2,322 Added 5.74%
42,761 $1.25 Million
Q4 2022

Feb 08, 2023
SELL
$17.65 - $27.37 $11,896 - $18,447
-674 Reduced 1.64%
40,439 $1.07 Million
Q3 2022

Oct 25, 2022
SELL
$22.62 - $32.54 $1.47 Million - $2.12 Million
-65,057 Reduced 61.28%
41,113 $954,000
Q2 2022

Aug 12, 2022
BUY
$22.88 - $39.45 $26,426 - $45,564
1,155 Added 1.1%
106,170 $2.67 Million
Q1 2022

May 11, 2022
BUY
$31.69 - $43.29 $1.51 Million - $2.06 Million
47,673 Added 83.14%
105,015 $4.01 Million
Q4 2021

Feb 08, 2022
BUY
$35.2 - $52.6 $327,852 - $489,916
9,314 Added 19.39%
57,342 $2.25 Million
Q3 2021

Nov 02, 2021
BUY
$46.35 - $59.75 $2.23 Million - $2.87 Million
48,028 New
48,028 $2.34 Million
Q2 2021

Aug 11, 2021
SELL
$47.2 - $67.81 $171,383 - $246,218
-3,631 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$30.93 - $59.48 $112,306 - $215,971
3,631 New
3,631 $202,000
Q2 2018

Aug 14, 2018
SELL
$9.6 - $14.6 $335,107 - $509,642
-34,907 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$5.7 - $12.3 $198,969 - $429,356
34,907 New
34,907 $347,000
Q3 2017

Nov 13, 2017
SELL
$3.0 - $6.0 $31,833 - $63,666
-10,611 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
10,611
10,611 $35,000

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.8M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.7B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email